文献速递生殖医学

子宫肌瘤与不明原因不孕患者卵巢刺激-宫腔内人工授精后妊娠结局的关联

Association of uterine fibroids and pregnancy outcomes after ovarian stimulation-intrauterine insemination for unexplained infertility.
PubMed 文献 · Fertil Steril · 2017-01-12

本研究为前瞻性随机多中心临床试验的二次分析,纳入900对不明原因不孕夫妇,随机接受克罗米芬、来曲唑或促性腺激素卵巢刺激-宫腔内人工授精(OS-IUI)治疗最多4个周期。102/900(11.3%)参与者至少有一个 documented 肌瘤且宫腔正常。有肌瘤者临床妊娠率在受孕周期中显著低于无肌瘤者,但受孕率和活产率无差异。结论认为非宫腔变形性肌瘤不影响OS-IUI的妊娠成功。

要点

  • 非宫腔变形性子宫肌瘤患者在接受OS-IUI时,受孕率和活产率与无肌瘤者无显著差异。
  • 有肌瘤者在受孕周期中的临床妊娠率显著低于无肌瘤者。
  • 非洲裔美国女性合并肌瘤者早期妊娠丢失风险高于非非洲裔美国女性合并肌瘤者。

核心结论

  • 非宫腔变形性子宫肌瘤患者与无肌瘤者相比,受孕率和活产率无差异。
  • 这些发现为非宫腔变形性肌瘤夫妇接受OS-IUI治疗的不明原因不孕提供了妊娠成功率不受影响的保证。

研究设计与样本

  • 研究设计为前瞻性随机多中心临床试验(AMIGOS)的二次分析。
  • 纳入900对不明原因不孕夫妇,随机分配至克罗米芬、来曲唑或促性腺激素三组之一,治疗最多4个周期或直至妊娠。
  • 研究在生殖医学网络临床中心进行。
  • 临床试验注册号:NCT01044862。

主要发现

  • 102/900(11.3%)参与者至少有一个记录的肌瘤且宫腔正常。
  • 有肌瘤的女性年龄更大、更可能为非洲裔美国人、子宫体积更大、血清抗苗勒管激素水平更低、窦卵泡数更少。
  • 在受孕周期中,有肌瘤参与者的临床妊娠率显著低于无肌瘤者。
  • 非洲裔美国女性合并肌瘤者发生12周前妊娠丢失的可能性高于非非洲裔美国女性合并肌瘤者。
  • 有和无肌瘤受试者的受孕率和活产率无差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the association of non-cavity-distorting uterine fibroids and pregnancy outcomes after ovarian stimulation-intrauterine insemination (OS-IUI) in couples with unexplained infertility. DESIGN: Secondary analysis from a prospective, randomized, multicenter clinical trial investigating fertility outcomes after OS-IUI. SETTING: Reproductive Medicine Network clinical sites. PATIENT(S): Nine hundred couples with unexplained infertility who participated in the Assessment of Multiple Intrauterine Gestations from Ovarian Stimulation (AMIGOS) clinical trial. INTERVENTION(S): Participants were randomized to one of three arms (clomiphene citrate, letrozole, or gonadotropins), and treatment was continued for up to four cycles or until pregnancy was achieved. MAIN OUTCOMES MEASURE(S): Conception (serum hCG increase), clinical pregnancy (fetal cardiac activity), and live birth rates. RESULT(S): A total of 102/900 participants (11.3%) had at least one documented fibroid and a normal uterine cavity. Women with fibroids were older, more likely to be African American, had a greater uterine volume, lower serum antimüllerian hormone levels, and fewer antral follicles than women without fibroids. In conception cycles, clinical pregnancy rates were significantly lower in participants with fibroids than in those without uterine fibroids. Pregnancy loss before 12 weeks was more likely in African American women with fibroids compared with non-African American women with fibroids. There was no difference in conception and live birth rates in subjects with and without fibroids. CONCLUSION(S): No differences were observed in conception and live birth rates in women with non-cavity-distorting fibroids and those without fibroids. These findings provide reassurance that pregnancy success is not impacted in couples with non-cavity-distorting fibroids undergoing OS-IUI for unexplained infertility. CLINICAL TRIAL REGISTRATION NUMBER: NCT01044862.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Styer AK, Jin S, Liu D, et al. Association of uterine fibroids and pregnancy outcomes after ovarian stimulation-intrauterine insemination for unexplained infertility. Fertil Steril. 2017. PMID: 28089575. doi:10.1016/j.fertnstert.2016.12.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。